Finding the Evidence Approximately 8,000 completed references are added to MEDLINE each week (over 400,000 added per year) Too much for any one person.

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Advertisements

Agency for Healthcare Research and Quality (AHRQ)
“The American health care delivery system is in need of fundamental change.” Crossing the Quality Chasm, IOM 2001.
 Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease:
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
JNC 8 Guidelines….
99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
Improving Diagnosis and Management of Hypertension: Implementation of Ambulatory Blood Pressure Monitoring in Primary Care* Scot B. Sternberg, MS; Kristine.
CMS Core Measures Evidence-Based Performance Measurement.
“Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure (GWTG-HF)” Daniel E. Forman, MD; Christopher.
Grinols and Mustard Impact of a casino opening on crime rates Concern: casinos are not random – opened in struggling areas Data at county/year level –
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Hospitalizations for Severe Sepsis Among Elderly Medicare Beneficiaries William Buczko, Ph.D. Research Analyst Centers for Medicare & Medicaid Services.
“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich,
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology.
L References Application to Clinical Practice The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have cooperatively.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.
The Value Of In-vitro Diagnostics Healthcare challenges in the 21 st century for governments & hospitals & how in-vitro diagnostics can contribute to overcoming.
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
Dr.F Eslamipour DDS.MS Orthodontist Associated professor Department of Oral Public Health Isfahan University of Medical Science.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
Washington State Medical Assistance Administration Disease Management Program Alice Lind, RN, MPH June 2004.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
Acute Myocardial Infarction (Heart Attack) Committee Membership: B. Majcher, APRN, C. Mulhall, APRN, K. McLean, MD, M. Jarotkiewicz RRT, MS, Administrative.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
The Effects of Health Plan Performance Measurement on Quality of Care for Medicare Beneficiaries Presented by Kate Bundorf Co-authors: Laurence Baker and.
Using the Electronic Health Record to Encourage Evidence-Based Practice Jonathan S. Einbinder, MD, MPH Partners HealthCare
Empowering Nurses to Provide Smoking Cessation Advice Team Members: Loyola Smoking Cessation Task Force.
Evidence-Based Medicine – Definitions and Applications 1 Component 2 / Unit 5 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,
Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Which Beta-Blocker is Best for Patients with Heart Failure? Summary and Comment by Joel M. Gore, MD Published in Journal Watch Cardiology December 17,
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Self-Management Support Strategies for Improving your Patients’ CVD Risk Bonnie Jortberg PhD, RD, CDE Robyn Wearner RD, MA Department of Family Medicine.
CR-1 Candesartan in HF Benefit/Risk James B. Young, MD Cleveland Clinic Foundation.
Treatment Guidelines and Disease State Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of Guideline-Based Admission Treatments.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Promoting Health Information Technology Linda Magno Director, Medicare Demonstrations Group.
Ventilator-associated Pneumonia Among Elderly Medicare Beneficiaries in Long-term Care Hospitals William Buczko, Ph.D. Research Analyst Centers for Medicare.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Presidential address: quality of cardiovascular.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
Associate Professor, Honorary Consultant Cardiologist
Patient populations by study group figure 10
Courtney selby, Pharm.d. arcare pgy1 Community pharmacy resident
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Health and Disease Management
Fewer PCIs After Public Reporting Changes in NY
RCHC’s Cardiovascular Health Initiative
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Global Registry of Acute Coronary Events: GRACE
No Financial Disclosure or Conflict of Interest
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Cardiac Rehab Riya Pulicharam, MD National Medical Director,
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Clinical Guidelines: Building Blocks for Effective Chronic Illness Care Jean Slutsky, P.A., M.S.P.H. Director, National Guideline Clearinghouse Project Director, US Preventive Services Task Force U.S. Agency for Healthcare Research and Quality “Slutsky intro”

Finding the Evidence Approximately 8,000 completed references are added to MEDLINE each week (over 400,000 added per year) Too much for any one person to evaluate Uncertainty results in: variations in care under and over utilization of services “evidence”

Putting Evidence into Practice It may take as long as 17 years for original research to be put into routine clinical practice Source: Balas EA, Boren SA. Managing Clinical Knowledge for Health Care Improvement. Yearbook of Medical Informatics. Schattauer, 2000: 65-70. “Evidence-practice”

Documented Variation in Treatment of Congestive Heart Failure 69 hospitals in 5 states; 2077 patients with CHF “variation” Source: Effective Clinical Practice, March/April 2000

Under-use of Beta-blockers Despite strong evidence that use of beta-blockers following acute myocardial infarction (AMI) decreases morbidity and mortality, they are substantially under used in the elderly. Beta-blocker prophylaxis after AMI is one of the most scientifically substantiated, cost-effective medical services. Their use decreases cardio-vascular mortality and reinfarctions, and increases survival by 20% to 40%. Under use leads to excess 2-year mortality and re-hospitalization for cardiovascular disease. “beta-blockers” Source: JAMA January 8, 1997; 277: 115-121

Under-use of Beta-blockers (cont’d) Only 21% of eligible New Jersey Medicare beneficiaries received beta-blocker therapy following their heart attack. Calcium channel blockers were used almost 3 times as often despite a lack of evidence that they decreased mortality. Patients on beta-blockers were re-hospitalized 22% less often and their mortality rate was 43% lower than non-recipients. Patients receiving calcium channel blockers instead of beta-blockers doubled their risk of death Source: JAMA January 8, 1997; 277: 115-121 “under-beta”

Examples of Quality of Chronic Health Care 52% of elderly adults received a flu shot in 1993 33% of hospitalized elderly discharged on an anti-depressant were on a dose below recommended level 49% of diabetic adults had dilated eye exam in past year 43% of patients who should have received coronary angiography received it within 3 months “examples” Source: M.A. Schuster et al., Milbank Q, 1998; 76:517-563

Chronic Care Management Do the RIGHT thing to the RIGHT patient at the RIGHT time. “CCMgmnt”

Guidelines Can Improve Clinical Decisions Clinical guidelines based on critical appraisal of scientific evidence (evidence-based guidelines) clarify which interventions are of proven benefit and document quality of supporting data. Alert clinicians to interventions unsupported by good science Reinforce the importance and methods of critical appraisal Call attention to ineffective, dangerous, and wasteful practices Source: BMJ 1999;318:527-530 ( 20 February ) “guidelines”

“NGCweb1”

“NGCWeb2”

“NGCWeb3”

“NGCWeb4”

In Summary Chronic illness care should be based on the best available evidence “Stop, look, and listen” and make sure that you know what you are using: who developed it, how good is the information, and is it current www.guideline.gov provides access to evidence-based guidelines “Summary”